Background: The etiology of Kawasaki disease (KD) is unknown. In Japan, the number of patients and incidence rate of KD has increased continuously since its discovery. The aim of this report was to analyze the latest nationwide epidemiological survey of KD in Japan. Methods: The 23rd nationwide survey of KD was conducted in 2015. To report on all patients diagnosed with KD in 2013 and 2014, a questionnaire was sent to hospitals with ≥100 beds containing pediatric departments, as well as specialized pediatric hospitals.
In 1967, Dr T. Kawasaki first reported 50 patients with Kawasaki disease (KD). 1 In the almost 50 years since then, >300 000 patients have been recorded in Japan. 2 Despite many proposed hypotheses as to the cause of KD, [3] [4] [5] the etiology remains elusive. Infants are the group most likely to have this disease, which causes systemic vasculitis. 6, 7 Coronary arteries are primarily affected, leading to cardiac sequelae. The most serious cardiac lesions are giant coronary aneurysms, which are associated with unfavorable outcomes. [8] [9] [10] [11] [12] [13] In Japan, results of 22 nationwide epidemiological surveys of KD have been reported since 1970. 2, [14] [15] [16] [17] [18] [19] These studies have shown that the number of patients and incidence rate of KD are increasing annually and suggest that KD is caused by infectious agents, precipitating an excessive auto-inflammatory response in genetically predisposed individuals. Fujita et al. 20 reported an unusually high incidence of the disease in twins, with a short interval between onsets, indicating either a common exposure to an infectious agent or a genetic predisposition. Although epidemiological data have recently implicated the densely cultivated region of northeastern China as the source of windborne transmission of the etiologic agent of KD, 21 that hypothesis could not explain some data.
Given that the cause of the accumulation of KD cases remains unclear, it is important to continually monitor epidemiological trends. Here, we report the results of the most recent nationwide survey of KD, which was conducted in Japan in 2015.
Methods
We conducted a retrospective survey of patients diagnosed with KD in 2013 and 2014. This survey was approved in advance by the Bioethics Committee for Epidemiologic Research, Jichi Medical University (10 October 2014, no. 14-50). We used the Listing of Hospitals 2003-2004 compiled by the Committee on Studies of Health Policies, Ministry of Health, Labour and Welfare, Japan, to select medical facilities meeting one of the following criteria: (i) hospitals specializing in pediatrics; or (ii) hospitals with a pediatric department and a capacity of ≥100 beds. A total of 1,973 facilities met these conditions for inclusion.
We sent a questionnaire (Table 1) and diagnostic guidelines to the doctors by mail. Returned questionnaires were assessed for completion and coherence, and returned to responders for revision when necessary. The background to the diagnosis in each case, however, had not been recorded. This method and these criteria have been used since the first nationwide survey in 1970. 22 Almost all items included in the questionnaire have also been used since the first nationwide survey. The diagnostic guidelines were created by the Japan Kawasaki Disease Research Committee. 23 We classified typical definite cases (patients with five or six of the six principal symptoms specified in guidelines for the diagnosis of KD) and atypical definite cases (patients with four of the six principal symptoms who had coronary artery aneurysm, as confirmed on coronary angiography or on 2-D echocardiography in the course of treatment) as complete cases. We classified incomplete cases as not meeting the diagnostic criteria, but which was suspected as KD by the reporting pediatricians. Cardiac lesions were recorded at the time of first visit and at the acute phase, and the presence of cardiac sequelae was examined after 1 month. Cardiac lesions were stated according to the judgment of each doctor based on 2-D echocardiography. Giant aneurysm was defined as ≥8 mm.
The i.v. immunoglobulin (IVIG) non-responsiveness was defined as persistent fever ≥24 h after the end of, or recurrent fever ≤24 h after a total Ig dose 2 g/kg, based on the 2010 KD Society Terminology Committee Draft of the Japanese Society of Kawasaki Disease.
Incidence rates were calculated using population data from the vital statistics of Japan. 24 
Results
We asked 1,973 hospitals to participate in this survey. The number of patients and the incidence rate of KD from 1964 to 2014 are shown in Figure 1 . As previously reported, there were three large nationwide epidemics of KD in 1979 KD in , 1982 KD in and 1986 . Although no national epidemics have occurred since 1986, the number of patients and the incidence rate of KD has increased continuously, reaching 308.0 (342.2 for male and 272.0 for female subjects) in 2014, the highest rate ever observed in Japan.
When the number of patients with KD was examined according to month from 2001 through 2014, the number of patients showed a clear peak in January, and a gradual increase in summer (Fig. 2) . The peaks for the winters of 2009 and 2010 were lower than in previous years. Atypical definite, four of the six principal symptoms and coronary artery aneurysm confirmed on coronary angiography or 2-D echocardiography in the course of treatment; incomplete, not meeting the diagnostic criteria but reported as suspected KD by the pediatrician; IVIG, i.v. immunoglobulin; KD, Kawasaki disease; typical definite, five or six of the six principal symptoms specified in guidelines for the diagnosis of KD. We next analyzed the age-specific incidence rate according to sex from 2013 through 2014. As in previous surveys, the incidence rate was highest in children aged between 9 and 11 months, after which the incidence rate gradually decreased with advancing age (Fig. 3) .
The KD patients were also classified according to diagnosis type. Of the 31 675 patients reported, 24 872 (78.5%) had typical definite KD, 612 (1.9%) had atypical definite KD, 6,185 (19.5%) had incomplete KD, and six had unknown diagnosis.
The number of patients with one or more siblings affected by KD was 592 (1.9%; male, n = 338; female, n = 254); and 315 patients (1.0%; male, n = 193; female, n = 122) had at least one parent (146 fathers, 163 mothers and six unknown) with a history of KD. There were 1,329 cases of recurrence (3.5%; male, n = 796; female, n = 533). Of the 31 675 patients reported, eight patients died (six boys and two girls), all classified as having typical KD (Table 2 ). Age at first hospital visit ranged from 0 to 4 years (two aged 0-5 months, two aged 6-11 months, three aged 1 year, and one aged 4 years). Four patients had received steroid therapy, and the others had not.
The proportion of patients with cardiac lesions, judged by each doctor, was examined between 2013 and 2014 (Table 3 ; Fig. 4) . At the first hospital visit, 1,339 patients (4.2%) had one or more cardiac lesions. During the acute phase, 2,696 The sum of the percentages of the individual cardiac lesions exceeds the total percentage of cardiac lesions because some patients had one or more cardiac lesions. † ≥8 mm in diameter. CA, coronary aneurysm; CD, coronary dilation; CS, coronary stenosis; KD, Kawasaki disease; MI, myocardial infarction. © 2018 Japan Pediatric Society (8.5%) had one or more cardiac lesions. Furthermore, 822 patients (2.6%) had cardiac sequelae 1 month after the onset of KD. Cardiac abnormalities were more prevalent in male patients than in female patients. The male/female ratio was 1.86 at first visit, 1.96 during the acute phase, and 2.33 with sequelae.
Early IVIG is recommended for KD patients aged <2 years. In the present survey, IVIG was given to 29 322 patients (92.6%; 92.6% of male and 92.5% of female patients). Treatment started on the fifth day of illness in almost all cases.
A total, however, of 5,024 (17.1%) of the 29 322 patients treated with IVIG did not respond to treatment, with non-responders more common in male patients than female patients (Table 4 ). They received one or more additional treatments as follows: 4,654 (92.6% of non-responders) received additional IVIG therapy, 1,651 (32.9%) received steroids, 283 (5.6%) received infliximab, 262 (5.2%) received immunosuppressants, and 136 (2.7%) underwent plasmapheresis.
Discussion
In this report we have described the most recent epidemiological features of KD in Japan. The number of patients and the incidence rate of KD has increased continuously, reaching 308.0 (342.2 for male and 272.0 for female subject) in 2014, the highest rate ever observed in Japan. The etiology of KD and the reasons for these increases are still unclear. These findings are therefore important to the continued observation of epidemiological KD trends.
We used criteria designed to select all hospitals catering for children with KD for participation in this survey. We believe that by using this method, the survey includes the majority of patients diagnosed with KD in Japan in 2013 and 2014. 19 We cannot, however, avoid bias due to exclusion of patients who may have received treatment in medical settings other than the target hospitals, such as small clinics that are not covered by the studied facilities.
In addition, the total number of patients is likely to be slightly higher, due to a response rate of 74.9%, despite two reminders. It is important to know the reason for the lack of reply, but it has not been determined in this survey. This response rate is consistent with previous survey response rates, which have remained at approximately 70% over the past 10 years. In our experience, it is difficult to achieve higher response rates in large-scale nationwide surveys. As discussed, however, in detail in a previous study in Tochigi on 1998, approximately 80% of KD patients identified according to health-care cost codes, were reported to the nationwide survey. 25 Therefore, we speculate that the actual number of cases is likely to be up to 10% higher than the values calculated from this survey.
The seasonal epidemiological features of KD appear very similar over a period of 14 years (Fig. 2) . 15 In Japan, a distinct peak of KD incidence is observed in January, as well as a more gradual increase in summer. This pattern supports the hypothesis that the disease is caused by multiple infectious agents, one prevalent in winter and another in summer. 19, 26 Further supporting this hypothesis, the seasonality of KD differs by region, 27, 28 which could be explained by regional variation in the presence of different agents. The epidemiological features of epidemic years (1979, 1982, and 1986 ) also support the infectious agent hypothesis. 19 Furthermore, the seasonal patterns in 2009 and 2010 differed from other years, with lower January peaks than in previous years. In 2009, influenza A/H1N1pdm was prevalent in Japan. 29 This influenza epidemic may have effected changes in the pattern of KD in 2009 and 2010 through interactions with other infectious agents. 19 These findings support the hypothesis that infectious agents are involved in the etiological mechanism of KD. In contrast, the potential associations between parents and childen, 30 as well as between siblings, 20 are supported by the present finding that 1.9% and 1% of KD patients, respectively, had a sibling or a parent with a history of the disease, indicating a genetic cause. Because we have not studied details regarding siblings and parents in this survey, we cannot investigate them. It is necessary, however, to investigate the age of siblings, the time of onset of KD in these siblings and the coronary artery outcome of parents. From the surveys so far, we assume that both environmental triggers and host factors are involved in KD.
Although IVIG was an effective treatment and was used in 92.6% of patients, it was withheld in approximately 8% of KD patients. We speculate that some recovered before using it and some refused to receive it.
One of the most serious complications of KD is cardiac sequelae. Because the nationwide survey can include almost all mild cases, the data are accurate. This symptom is the most important factor influencing mortality rate in the long-term outcomes of KD. 31 Fortunately, as shown in this study, the proportion of cases involving cardiac sequelae has decreased substantially, likely due to advances in the treatment of KD.
The American Heart Association definition allows for fevers in the first 36 h following the end of IVIG infusion. 32 In contrast, in Japan, non-response is defined as persistent fever ≥24 h after the end of, or recurrent fever ≤24 h after, a total Ig dose 2 g/kg, and pediatricians use a second treatment for fever >24 h following the end of IVIG infusion. In the present study, however, the proportion of non-responders in Japan was low, therefore, this could not be compared with other countries.
One important result to note is that eight patients died during the survey period (Table 2 ). Since Kato et al. 33 reported a potential adverse effect of steroids, leading to progression of coronary lesions, Ig therapy has been widely favored in KD treatment. In recent years, however, steroids have been reevaluated, in accordance with the RAISE study, 34 which showed increased efficacy of IVIG plus prednisolone in reducing the incidence of coronary artery abnormalities in KD, compared with IVIG alone. It is necessary to examine the relevance of steroid use to KD death. We will examine the data from these patients in detail and report the findings in a separate article.
In conclusion, in the 23rd nationwide survey of KD in Japan, the number of patients and incidence rate of KD continued to steadily increase in 2013 and 2014. Continued surveillance of KD trends is therefore required.
